DGX - Quest Diagnostics Incorporated

NYSE - Nasdaq Real Time Price. Currency in USD
101.76
+1.19 (+1.18%)
As of 9:43AM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close100.57
Open102.50
Bid99.94 x 900
Ask101.15 x 2200
Day's Range100.32 - 101.76
52 Week Range78.95 - 116.49
Volume19,944
Avg. Volume1,106,515
Market Cap13.674B
Beta (3Y Monthly)0.90
PE Ratio (TTM)19.49
EPS (TTM)5.22
Earnings DateJul 23, 2019
Forward Dividend & Yield2.12 (2.11%)
Ex-Dividend Date2019-07-05
1y Target Est99.50
Trade prices are not sourced from all markets
  • DGX vs. CHE: Which Stock Is the Better Value Option?
    Zacksyesterday

    DGX vs. CHE: Which Stock Is the Better Value Option?

    DGX vs. CHE: Which Stock Is the Better Value Option?

  • Is Quest Diagnostics Incorporated (NYSE:DGX) A Smart Pick For Income Investors?
    Simply Wall St.yesterday

    Is Quest Diagnostics Incorporated (NYSE:DGX) A Smart Pick For Income Investors?

    Today we'll take a closer look at Quest Diagnostics Incorporated (NYSE:DGX) from a dividend investor's perspective...

  • GuruFocus.com2 days ago

    Quest Diagnostics Inc (DGX) Chairman, President and CEO Stephen H Rusckowski Sold $24. ...

    Chairman, President and CEO of Quest Diagnostics Inc (NYSE:DGX) Stephen H Rusckowski sold 244,565 shares of DGX on 06/13/2019 at an average price of $100 a share.

  • Bloomberg2 days ago

    Debt Collector Goes Bankrupt After Health Care Data Hack

    (Bloomberg) -- Retrieval-Masters Creditors Bureau Inc., whose business was blamed for a large-scale data breach that affected millions of Quest Diagnostics Inc. customers, filed for Chapter 11 protection, citing fallout from the security issue.The company, which collects patient receivables for medical labs under the name American Medical Collection Agency, listed assets and liabilities of as much as $10 million in its bankruptcy petition filed in the Southern District of New York. It’s aiming to liquidate, the company said.Court documents cited a breach discovered in March that affected millions of people, including customers of Quest Diagnostics and Laboratory Corporation of America. Soon after, Quest, LabCorp, Conduent Inc. and CareCentrix Inc. -- American Medical’s four largest clients -- stopped doing business with the company, leading to the bankruptcy filing, according to court papers.A representative for Retrieval-Masters didn’t provide a comment.Cascading EventsThe data breach created a “cascade of events” resulting in the bankruptcy filing, Chief Executive Officer Russell H. Fuchs said in a court declaration. It incurred “enormous expenses that were beyond the ability of the debtor to bear,” he said.Those expenses included more than $3.8 million spent on mailing more than 7 million individual notices to people whose information had been potentially hacked. Fuchs personally lent the company $2.5 million to help pay for those mailings, he said in the declaration. In addition, IT professionals and consultants hired in connection with the breach had cost Retrieval-Masters about $400,000 by the time of the filing.The Elmsford, New York-based company learned of the breach after receiving notices saying a high number of credit cards tied to its web portal were connected to fraudulent charges, Fuchs said. Quest is facing a lawsuit in California and inquiry in Michigan about the breach.Retrieval-Masters has slashed staff to 25 from 113 at the end of 2018, according to court papers.Retrieval-Masters also collects non-medical consumer debt, according to its website. Fuchs founded the company in 1977 and was initially focused on small-dollar debt collections for direct-mail marketers, such as the various book-of-the-month or record clubs that predated the e-commerce boom, before transitioning into patient receivables, the declaration shows.The case is Retrieval-Masters Creditors Bureau Inc., 19-23185, U.S. Bankruptcy Court for the Southern District of New York (White Plains)(Updates to include impact on LabCorp customers.)To contact the reporter on this story: Jeremy Hill in New York at jhill273@bloomberg.netTo contact the editors responsible for this story: Rick Green at rgreen18@bloomberg.net, Nicole BullockFor more articles like this, please visit us at bloomberg.com©2019 Bloomberg L.P.

  • Employer Wellness Screening with Digital Diabetes Prevention Program May Lower Eight-Year Risk of Diabetes, Suggests Quest Diagnostics Study
    PR Newswire2 days ago

    Employer Wellness Screening with Digital Diabetes Prevention Program May Lower Eight-Year Risk of Diabetes, Suggests Quest Diagnostics Study

    SECAUCUS, N.J., June 17, 2019 /PRNewswire/ -- Individuals with prediabetes who participate in an employer-sponsored digital diabetes-prevention counseling program may reduce their risk of developing type 2 diabetes (T2D) for up to eight years, according to a new study from Quest Diagnostics (DGX), the world's leading provider of diagnostic information services. The new study, "Digital Behavioral Counseling in a Workforce Setting Reduces 8-Year Risk of Developing Type 2 Diabetes" (77-LB), is believed to be the first to suggest lower risk of diabetes may be sustained following participation in a time-limited digital Diabetes Prevention Program (DPP).

  • Markit8 days ago

    See what the IHS Markit Score report has to say about Quest Diagnostics Inc.

    Quest Diagnostics Inc NYSE:DGXView full report here! Summary * Perception of the company's creditworthiness is neutral * Bearish sentiment is low * Economic output for the sector is expanding but at a slower rate Bearish sentimentShort interest | PositiveShort interest is low for DGX with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Money flowETF/Index ownership | NeutralETF activity is neutral. ETFs that hold DGX had net inflows of $5.19 billion over the last one-month. While these are not among the highest inflows of the last year, the rate of inflow is increasing. Economic sentimentPMI by IHS Markit | NegativeAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however, and is easing. Credit worthinessCredit default swap | NeutralThe current level displays a neutral indicator. DGX credit default swap spreads are within the middle of their range for the last three years.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

  • GlobeNewswire9 days ago

    Bragar Eagel & Squire, P.C. is Investigating Certain Officers and Directors of Quest Diagnostics Incorporated (NYSE: DGX) and Encourages Quest Diagnostics Investors to Contact the Firm

    NEW YORK, June 09, 2019 -- Bragar Eagel & Squire, P.C. is investigating potential claims against certain officers and directors of Quest Diagnostics Incorporated (NYSE:.

  • Business Wire11 days ago

    QUEST DIAGNOSTICS INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Quest Diagnostics Incorporated - DGX

    Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC , announces that KSF has commenced an investigation into Quest Diagnostics Incorporated .

  • PR Newswire13 days ago

    Faruqi & Faruqi, LLP is Investigating Quest Diagnostics Incorporated (DGX) on Behalf of its Shareholders

    NEW YORK , June 6, 2019 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential misconduct at Quest Diagnostics Incorporated ("Quest Diagnostics" ...

  • Reuters13 days ago

    UPDATE 1-Opko Health says over 400,000 customers likely affected by data breach

    Opko Health Inc said on Thursday it was notified by its former billing collections vendor about unauthorized access to information on about 422,600 customers, making it the third healthcare company to be affected by the incident. American Medical Collection Agency (AMCA) informed Opko Health that the compromised data may include credit card and bank account information, email addresses and other data such as address, phone number and balance information. Earlier this week, rivals Quest Diagnostics Inc and Laboratory Corporation of America Holdings also announced that they were apprised of unauthorized access to their customer data stored on AMCA system.

  • Here's Why You Should Invest in Quest Diagnostics (DGX) Stock
    Zacks13 days ago

    Here's Why You Should Invest in Quest Diagnostics (DGX) Stock

    Quest Diagnostics (DGX) is boosting investors' optimism, courtesy of consistent positive results.

  • Senator warns of 'irreparable' consumer harm after data breach
    Yahoo Finance14 days ago

    Senator warns of 'irreparable' consumer harm after data breach

    Senators demand answers from Quest Diagnostics and LabCorp after a data breach may have put millions of consumers' information at risk.

  • LabCorp (LH) Closes Envigo Swap Deal, Expands in CRO Space
    Zacks14 days ago

    LabCorp (LH) Closes Envigo Swap Deal, Expands in CRO Space

    The conclusion of LabCorp's (LH) swap transaction will help enhance the company's Covance global nonclinical drug development capabilities with additional sites and resources.

  • Quest Diagnostics: 12 million patients may have had personal information breached
    American City Business Journals16 days ago

    Quest Diagnostics: 12 million patients may have had personal information breached

    Quest Diagnostics Inc., one of the biggest blood testing providers in the country, has suffered a massive hack possibly affecting millions of its customers. The company confirmed Monday that nearly 12 million people may have had personal, financial and medical information breached due to an issue with one of its vendors. In a filing with the U.S. Securities and Exchange Commission, Quest explained that someone had unauthorized access to the systems of American Medical Collections Agency (AMCA), a billing services vendor.

  • Reuters16 days ago

    Quest Diagnostics says data breach could have hit 11.9 million patients

    The company has not received all the information about the incident from American Medical Collection Agency (AMCA) and has not been able to verify the accuracy of the information received from AMCA, the diagnostic information services provider said https://www.sec.gov/Archives/edgar/data/1022079/000094787119000415/ss138857_8k.htm. Optum360 LLC, a unit of UnitedHealth Group Inc, was also notified of the breach, according to Quest's regulatory filing. Optum360 provides customer billing services to Quest Diagnostics.

  • Quest Diagnostics says 11.9 million patients affected by data breach
    TechCrunch16 days ago

    Quest Diagnostics says 11.9 million patients affected by data breach

    Medical testing giant Quest Diagnostics has confirmed a third-party billingcompany has been hit by a data breach affecting 11

  • Simply Wall St.19 days ago

    Is Quest Diagnostics Incorporated's (NYSE:DGX) CEO Salary Justified?

    In 1970 Steve Rusckowski was appointed CEO of Quest Diagnostics Incorporated (NYSE:DGX). This analysis aims first to...

  • Quest Diagnostics Now Participating in NCI-MATCH Precision Medicine Clinical Trial
    PR Newswire21 days ago

    Quest Diagnostics Now Participating in NCI-MATCH Precision Medicine Clinical Trial

    SECAUCUS, N.J., May 29, 2019 /PRNewswire/ -- Quest Diagnostics (DGX), a leading provider of diagnostic information services, today announced it is participating as a designated laboratory in the NCI-Molecular Analysis for Therapy Choice (NCI-MATCH or EAY131) precision medicine trial, the largest precision medicine trial of its kind. The trial is co-led by the National Cancer Institute (NCI), part of the National Institutes of Health, and the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN). NCI-MATCH (EAY131) is a phase 2 precision medicine trial that seeks to determine the effectiveness of treatment that is directed by genomic profiling in patients with solid tumors, lymphomas, or myelomas that have progressed following standard treatments expected to prolong survival, or for rare cancer types for which there is no standard treatment.

  • Quest Diagnostics Warns 12 Million Patients May Be Impacted by Data Breach
    Meredith Videos15 days ago

    Quest Diagnostics Warns 12 Million Patients May Be Impacted by Data Breach

    The blood testing company experienced something similar in 2016.

  • News on the Move: Disaster Relief Bill, James Holzhauer on Jeopardy and more
    Yahoo Finance Video15 days ago

    News on the Move: Disaster Relief Bill, James Holzhauer on Jeopardy and more

    Yahoo Finance's Adam Shapiro fills you in on the latest news stories that you need to know.

  • Quest Diagnostics says nearly 12 million people may have been affected by hack
    CBS News Videos16 days ago

    Quest Diagnostics says nearly 12 million people may have been affected by hack

    Nearly 12 million Quest Diagnostics patients may have had personal information exposed in a data breach. The information includes financial data, Social Security numbers and medical records, though the company said laboratory test results were not exposed. Quest Diagnostics is the world's largest blood-testing company.